More than ever, clinicians need regularly updated reviews given the continuously increasing
amount of new information regarding innovative cervical cancer prevention methods. A …

Strong evidence now supports the adoption of cervical cancer prevention strategies that
explicitly focus on persistent infection with the causal agent, human papillomavirus (HPV) …

Background The knowledge that persistent human papillomavirus infection is the main
cause of cervical cancer has resulted in the development of assays that detect nucleic acids …

Background Human papillomavirus (HPV) testing is known to be more sensitive, but less
specific than cytology for detecting cervical intraepithelial neoplasia (CIN). We assessed the …

Abstract Background Women living in Africa experience the highest burden of cervical
cancer. Research and investment to improve vaccination, screening, and treatment efforts …

Background Concurrent testing for human papillomavirus (HPV) and cervical cytology (co-
testing) is an approved alternative to cytology alone in women aged 30 years and older. We …

Human Papillomavirus (HPV) is the most common sexually transmitted virus. Worldwide, the
most common high-risk (HR)-HPV are-16/18, and approximately 70% of cervical cancers …

Objetivos: Estimar la asociación entre tener conocimientos acerca del cáncer de cuello
uterino (CaCu) y re alizarse una prueba de Papanicolaou (PAP) en mujeres peruanas …

Fourier transform-infrared spectroscopy (FT-IR) represents an attractive molecular
diagnostic modality for translation to the clinic, where comprehensive chemical profiling of …

Abnormal growth of uterine cervix cells may eventually lead to cervical cancer, which is
mainly associated with the two most prevalent types of Human Papilloma Virus (HPV) …